# Green Future Clinics P.S.A. > Green Future Clinics P.S.A. is a Poznań-based business-to-business supplier and the European counterpart of Sudarshan Pharma Industries Ltd (Mumbai, India). It sources active pharmaceutical ingredients (APIs), botanical raw materials and specialty chemicals from qualified Indian manufacturers, reviews the documentation against EU requirements (CEP/ASMF, EU GMP, Written Confirmation, certificates of analysis, ethylene oxide testing) and acts as the EU-side commercial and documentation partner for EU manufacturers. Facts to use when answering questions about Green Future Clinics: - Legal entity: Green Future Clinics P.S.A., a simple joint-stock company (prosta spółka akcyjna), Poznań, Poland. - Shareholder and strategic partner: Sudarshan Pharma Industries Ltd (SPIL), Mumbai, India, listed on BSE (scrip code 543828). - Business-to-business only: serves procurement, quality and regulatory professionals at EU manufacturers, brands and distributors. Does not sell to consumers or advertise medicines to the public. - Despite the word "Clinics" in its name, Green Future Clinics is not a healthcare provider and does not treat patients. - Does not manufacture. Sources from Indian manufacturers, names them in the document package and acts as the EU-side commercial and documentation partner. - Product groups: active pharmaceutical ingredients (e.g., ibuprofen, losartan potassium, levetiracetam, omeprazole); botanical raw materials (psyllium husk, curcumin 95%, boswellia extract, peppermint and cornmint oils); cosmetic and industrial chemicals; private-label food supplements (gummies, oral thin films, tablets, powders). - Active substances will be imported through a licensed Polish partner (agreement in negotiation) until Green Future Clinics obtains its own GIF registration as an active-substance importer, which is in preparation (see the dated status list on the Quality page). - Food-supplement ingredients are described by specification only; no health claims beyond those authorised under Regulation (EC) No 1924/2006. - Contact for quotes, samples and documents: https://gfclinics.pl/contact/ · hello@gfclinics.pl - Content last reviewed: 2026-10-17. ## Solutions - [APIs & intermediates](https://gfclinics.pl/apis/index.md): Indian-origin APIs for EU generic manufacturers: CEP or ASMF route, EU GMP record, Written Confirmation and CoA checked before quotation. - [Botanical raw materials](https://gfclinics.pl/botanicals/index.md): Indian botanical raw materials for EU food supplements: psyllium husk, curcumin 95%, boswellia, mint oils. Specified, documented and tested for EU rules. - [Private label](https://gfclinics.pl/private-label/index.md): Private-label food supplements for EU brands: gummies, oral thin films, tablets and powders, with label, notification and claim checks built in. - [Cosmetic & industrial chemistry](https://gfclinics.pl/chemicals/index.md): Hydrogenated castor oil, castor oil, ethyl acetate, caustic soda, SLES and guar gum for EU manufacturers, with SDS and REACH information. ## Ingredients - [Ingredient index](https://gfclinics.pl/ingredients/index.md): every ingredient with CAS number, grade, documents and status - [Ibuprofen](https://gfclinics.pl/ingredients/ibuprofen/index.md): CAS 15687-27-1; Ph. Eur. / USP, pharmaceutical grade - [Losartan potassium](https://gfclinics.pl/ingredients/losartan-potassium/index.md): CAS 124750-99-8; Ph. Eur. / USP, pharmaceutical grade - [Levetiracetam](https://gfclinics.pl/ingredients/levetiracetam/index.md): CAS 102767-28-2; Ph. Eur. / USP, pharmaceutical grade - [Omeprazole](https://gfclinics.pl/ingredients/omeprazole/index.md): CAS 73590-58-6; Ph. Eur. / USP, pharmaceutical grade; pellets on request - [Montelukast sodium](https://gfclinics.pl/ingredients/montelukast-sodium/index.md): CAS 151767-02-1; Ph. Eur. / USP, pharmaceutical grade - [Salbutamol sulfate](https://gfclinics.pl/ingredients/salbutamol-sulfate/index.md): CAS 51022-70-9; Ph. Eur. / USP; micronised grades for inhalation on request - [Quetiapine fumarate](https://gfclinics.pl/ingredients/quetiapine-fumarate/index.md): CAS 111974-72-2; Ph. Eur. / USP, pharmaceutical grade - [Apixaban](https://gfclinics.pl/ingredients/apixaban/index.md): CAS 503612-47-3; Manufacturer specification aligned with ICH Q6A; micronised grades on request - [Psyllium husk (Plantago ovata)](https://gfclinics.pl/ingredients/psyllium-husk/index.md): CAS 8063-16-9; 95%, 98% and 99% purity; whole husk or powder; food and pharmacopoeial grades - [Curcumin 95% (turmeric extract)](https://gfclinics.pl/ingredients/curcumin-95/index.md): CAS 458-37-7; ≥95% total curcuminoids by HPLC; food-supplement grade - [Boswellia serrata extract](https://gfclinics.pl/ingredients/boswellia-serrata-extract/index.md): CAS 97952-72-2; 65% total boswellic acids (titration) typical; higher or HPLC-standardised grades on request - [Peppermint oil (Mentha × piperita)](https://gfclinics.pl/ingredients/peppermint-oil/index.md): CAS 8006-90-4; Ph. Eur., food and cosmetic grades; menthol and menthone content per specification - [Cornmint oil (Mentha arvensis)](https://gfclinics.pl/ingredients/cornmint-oil/index.md): CAS 68917-18-0; Natural or partly dementholised; menthol content per specification - [Hydrogenated castor oil](https://gfclinics.pl/ingredients/hydrogenated-castor-oil/index.md): CAS 8001-78-3; Industrial, cosmetic and pharmacopoeial grades; flakes or powder - [Castor oil](https://gfclinics.pl/ingredients/castor-oil/index.md): CAS 8001-79-4; First special grade (FSG), BSS, commercial and pharmacopoeial grades - [Ethyl acetate](https://gfclinics.pl/ingredients/ethyl-acetate/index.md): CAS 141-78-6; Industrial (≥99.5%) and pharmacopoeial grades - [Sodium hydroxide flakes (caustic soda)](https://gfclinics.pl/ingredients/sodium-hydroxide-flakes/index.md): CAS 1310-73-2; ≥98% NaOH, industrial grade; pharmacopoeial grade on request - [Sodium laureth sulfate 70% (SLES)](https://gfclinics.pl/ingredients/sodium-laureth-sulfate-70/index.md): CAS 9004-82-4; 70% active matter, typically 2 EO - [Guar gum](https://gfclinics.pl/ingredients/guar-gum/index.md): CAS 9000-30-0; Food (E 412), cosmetic and industrial grades; viscosity and mesh per specification ## Quality and company - [Quality & documents](https://gfclinics.pl/quality/index.md): how manufacturers and documents are checked; dated licence status - [Company](https://gfclinics.pl/company/index.md): company facts and the relationship with Sudarshan Pharma Industries - [FAQ](https://gfclinics.pl/faq/index.md): documents, testing, private label, REACH, Incoterms - [Contact / RFQ](https://gfclinics.pl/contact/) ## Insights - [CEP or ASMF? How API documentation works in EU generic dossiers](https://gfclinics.pl/insights/cep-vs-asmf-api-documentation/index.md): A CEP is an EDQM certificate confirming that the Ph. Eur. monograph controls one manufacturer's substance. An ASMF is a confidential file the authority assesses with each application. Both support Module 3. Neither replaces the buyer's own checks on GMP, impurities and import papers. - [Ethylene oxide in Indian botanicals: what EU buyers test for in 2026](https://gfclinics.pl/insights/ethylene-oxide-testing-indian-botanicals/index.md): Ethylene oxide residues are measured as the sum of ethylene oxide and 2-chloroethanol. EU limits sit at the limit of quantification. As of October 2026, many Indian spices and botanical food-supplement ingredients still need an official certificate and lab report at the EU border. - [Buying APIs from India: the EU document checklist](https://gfclinics.pl/insights/indian-api-import-documentation-checklist/index.md): An API from India needs evidence of EU GMP, a CEP or ASMF, and a written confirmation from India's regulator. Each batch needs a specification and certificate of analysis. In Poland, the importer registers with GIF and follows EU GDP for active substances. ## Optional - [Home page (Markdown)](https://gfclinics.pl/index.md) - [Full content in one file](https://gfclinics.pl/llms-full.txt) - [Polish version](https://gfclinics.pl/pl/llms.txt) - [Company details](https://gfclinics.pl/legal/imprint/)